Solventum Corporation has launched a $1 billion stock buyback program as it grapples with a 3% year-over-year revenue decline and a 4.8% drop in stock value, now trading at $75.48. The healthcare company also recently acquired Acera Surgical for $850 million, aiming to bolster its market position amid ongoing financial pressures. With a market cap of $13.31 billion, Solventum’s challenges include stagnant sales performance and a debt management strategy that includes a significant divestiture.
“SOL · is a · PERP · SOL PERP”
“Solventum Corporation · has · sales · $8.3 billion in sales in 2024”
“Solventum Corporation · has · professionals · 20,000+ professionals shaping the future of health”
“Solventum · reports · First Quarter 2026 Financial Results · on May 5, 2026”
“Solventum Corp. · operates as · health care company”
“Solventum Corp. · was founded on · January 24, 2023”
“Solventum Corp. · is headquartered in · Maplewood, MN”
“Solventum Corporation · has market cap of · $13.31B”
“Solventum Corporation · has price-earnings ratio of · 9.40”
“Solventum Corporation · has average volume of · 1.73M”
“Solventum’s medsurg products · are sold to · group purchasing organizations”
“Solventum Corporation · is listed on · New York Stock Exchange · SOLV”
